Despite the highest levels of serum VEGF-A being found among proliferative DR patients, a significant increase in serum VEGF-A is also described in the early stage of DR, i.e., in non-proliferative DR patients, as compared to type 2 diabetes mellitus subjects without retinopathy [34]. This evidence concerns the gene VEGFA and retinal disorder.